Development of non-effervescent floating matrix tablets based on Euryale ferox seeds
Main Article Content
Abstract
of this study was to develop non-effervescent floating matrix tablets using E. ferox seeds powder (EFSP). Different matrix tablets were prepared using hydroxy propyl methyl cellulose (HPMC) K4M, ciprofloxacin HCl and EFSP. The effects of
various formulation variables were investigated on in vitro drug release and in vitro floating behavior of the matrix tablets. With increase in EFSP proportion in the matrix tablets, improvement in buoyancy was observed. The floating behavior of tablets was also found to be dependent on particle size of EFSP. Further, surface morphology of different particle sizes of EFSP was studied with Scanning Electron Microscope images. Drug release from matrix tablets was reduced in the presence of EFSP particles. Most of the formulations were best fitted with Korsmeyer–Peppas and zero-order release kinetics. The value of n was found to be between 0.45 and 0.89, which indicates non-fickian drug transport. Thus, non-effervescent floating behavior can be successfully achieved by using EFSP in HPMC K4M based matrix tablets.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a
novel controlled-release system for gastric retention. Pharm Res
:14;815-9.
Talukder R, Fassihi R. Gastroretentive Delivery Systems: A Mini Review.
Drug Dev Ind Pharm 2004:30;1019-28.
Arora S, Javed A, Ahuja A, Khar RK, Baboota S. Floating drug delivery
system: A review. AAPS PharmSciTech 2005:6;E372-90.
Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper
small intestine window usinggastroretentive technologies. Curr Opin
Pharmacol 2006:6;501-8.
Rahman Z, Ali M, Khar RK. Design and evaluation of bilayer floating
tablets of captopril. Acta Pharm 2006:56;49-57.
Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. Oral sustained
delivery of atenolol from floating matrix tablets-formulation and in vitro
evaluation. Drug Dev Ind Pharm 2005;31:367-74.
Jiménez-MartÃnez I, Quirino-Barreda T, Villafuerte-Robles L. Sustained
delivery of captopril from floating matrix tablets. Int J Pharm
;362:37-43.
Ichikawa M, Watanabe S, Miyake Y. A new multiple unit oral floating
dosage system. I: Prepration and in vitro evaluation of floating and
sustained-release characteristics. J Pharm Sci 1991;80:1062-6.
Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous
calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm
Biopharm 2007:65;85-93.
Sriamornsak P, Sungthongjeen S, Puttipipatkhachorn S. Use of pectin as a carrier for intragastric floating drug delivery: Carbonate salt contained
beads. Carbohydr Polym 2007:67;436-45.
Rajinikanth PS, Balasubramaniam J, Mishra B. Development and
evaluation of a novel floating in situ gelling system of amoxicillin for
eradication of Helicobacter pylori. Int J Pharm 2007;335:114-22.
Strusi OL, Sonvico F, Bettini R, Santi P, Colombo G, Barata P, et al. Module assemblage technology for floating systems: In vitro flotation and in vivo gastro-retention. J Control Release 2008;129:88-92.
Gutiérrez-Sánchez PE, Hernández-León A, Villafuerte-Robles L. Effect
of sodium bicarbonate on the properties of metronidazole floating
matrix tablets. Drug Dev Ind Pharm 2008;34;171-80.
Russell TL, Berardi RR, Barnett JL, Dermentzoglou LC, Jarvenpaa KM,
Schmaltz SP, et al. Upper gastrointestinal pH inseventy-nine healthy,
elderly, North American men and women. Pharm Res 1993;10:187-96.
Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of
sustained release gastroretentive drug delivery system for ofloxacin:
In-vitro and in-vivo evaluation. Int J Pharm 2005:304;178-84.
Sauzet C, Claeys-Brunob M, Nicolasc M, Kister J, Piccerelle P, Prinderrea P. An innovative floating gastro retentive dosage system: Formulation and in vitro evaluation. Int J Pharm 2009;378:23-9.
Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based
on low density foam powder: Effects of formulation and processing
parameters on drug release. Eur J Pharm Sci 2003;18:37-45.
McGuffin, M, Hobbs, C, Upton, R. American products association’s
botanical safety handbook. Boca Raton, FL: CRC Press; 1997. p. 51.
Nath BK, Chakraborty AK. Studies on the physicochemical properties
of starch of Eurylae ferox. Starch 1985:37;361-3.
Lee SE, Ju EM, Kim JH. Antioxidant activity of extracts from Euryale
ferox seed. Exp Mol Med 2002;34:100-6.
Das S, Der P, Raychaudhuri U, Maulik N, Das DK. The effect of Euryale
ferox (makhana), an herb of aquatic origin, on myocardial ischemic
reperfusion injury. Mol Cell Biochem 2006;289:55-63.
Tadros MI. Controlled-release effervescent floating matrix tablets of
ciprofloxacin hydrochloride: Development, optimization and in vitro–in
vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm
;74:332-9.
Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation
of swellable and floating gastroretentive ciprofloxacin hydrochloride
tablets. AAPS PharmSciTech 2009;10:1220-6.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms
of solute release from porous hydrophilic polymers. Int J Pharm
;15:25-35.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution
profiles. Eur J Pharm Sci 2001;13:123-33.
Strübing S, Metz H, Mäder K. Characterization of poly (vinyl acetate)
based floating matrix tablets. J Control Release 2008;126:149-55.
Colombo P, Bettini R, Santi P, De Ascentiis A, Peppas NA. Analysis of
the swelling and release mechanisms from drug delivery systems with
emphasison drug solubility and water transport. J Control Release
;39:231-7.
Viridéna A, Wittgrenb B, Larsson A. Investigation of critical polymer
properties for polymer release and swelling of HPMC matrix tablets.
Eur J Pharm Sci 2009;36:297-309.
Peppas NA, A.R. Khare AR. Preparation, structure and diffusional
behavior of hydrogel in controlled release. Adv Drug Deliv Rev
;11:21-35.
Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of
novel nicorandil extended release matrix tablets based on hydrophilic
interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm
Biopharm 2008;69:1019-28.
Escudero JJ, Ferrero C, Jiménez-Castellanos MR. Compaction properties,
drug release kinetics and fronts movement studies from matrices
combining mixtures of swellable and inert polymers: Effect of HPMC
of different viscosity grades. Int J Pharm 2008;351:61-73.
Tajiri T, Morita S, Sakamoto R, Suzuki M, Yamanashi S, Ozaki Y, et al.
Release mechanisms of acetaminophen from polyethylene oxide/
polyethylene glycol matrix tablets utilizing magnetic resonance
imaging. Int J Pharm 2010;395:147-53.
Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. Drug
diffusion front movement is important in drug release control from
swellable matrix tablets. J Pharm Sci 1995;84:991-7.
Bettini R, Colombo P, Massimo G, Catellani PL, Vitali T. Swelling and
drug release in hydrogel matrices: Polymer viscosity and matrix porosity
effects. Eur J Pharm Sci 1994;2:213-9.
Colombo, P, Santi, P, Bettini, R, Brazel, CS, Peppas, NA. Drug release
from swelling-controlled systems. In: Wise DL, editors. Handbook of
pharmaceutical controlled release technology. New York: Marcel Dekker
Inc.; 2000. p. 190.
Ritger PL, Peppas NA. A simple equation for description of solute
release. I. Fickian and non-Fickian release from non-swellable devices
in the form of slabs, spheres, cylinders or discs. J Control Release
;5:23-36.
Ritger PL, Peppas NA. A simple equation for description of solute
release. II. Fickian and anomalous release from swellable devices. J
Control Release 1987;5:37-42.
Baveja SK, Rao KVR, Devi KP. Zero-order release hydrophylic matrix
tablets of -adrenergic blockers. Int J Pharm 1987;39:39-45.
Kim H, Fasshi R. Application of a binary polymer system in drug release
rate modulation. 1. Characterisation of release mechanism. J Pharm
Sci 1997:86:316-22.
Kim H, Fasshi R. Application of a binary polymer system in drug release
rate modulation. 2. Influence of formulation variables and hydrodynamic
conditions on release kinetics. J Pharm Sci 1997:86:323-8.
Lee PI. Diffusional release of a solute from a polymeric matrix-
approximate analytical solutions. J Memb Sci 1980;7:255-75.
Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/
polymer matrix swelling and dissolution. Pharm Res 1988;5:488-94.